-Deliver immersive solutions that deliver significant patient, health economics and equality benefits.
-Give every patient in hospital care access to their own VR headset.
-Give every patient outside hospital the opportunity to utilise VR care.
-Make VR empathy and experience training normal business practice.
Rescape’s first product - the now medical device DR.VR® is being used within the NHS, Care Homes and Hospices.
DR.VR® is a virtual reality distraction therapy solution that primarily supports pain relief, anxiety/stress and improves patient’s experience.
The modular DR.VR® platform is flexible, supporting multiple care and therapeutic pathways including being used within ICU reducing pain, anxiety and assisting in the recovery of patients. The iteration DR.VR® Junior is designed for Paediatric departments and is being used with leading UK Children’s hospitals. The DR.VR® platform is designed to be simple and straightforward to implement even with no prior VR experience.
During the pandemic Rescape developed DR.VR® Frontline with a targeted outcome of reducing anxiety of NHS frontline staff. Following a successful feasibility study commercial sales of DR.VR® are now underway.
DR.VR® has also been shown delivering a cost effective training solution into the care and blue light services.
Rescape is currently focusing on driving adoption within care pathways that can benefit from the impact that DR.VR® can make today and collaborations that build on the DR.VR® platform and technology for future patient benefits tomorrow.
Overview
FAQ about Rescape Innovation Ltd
When was Rescape Innovation Ltd founded?
Rescape Innovation Ltd was founded in 2017.
Is Rescape Innovation Ltd still active?
Yes, Rescape Innovation Ltd is active; its latest activity on Parsers VC dates from Jan 24, 2022.